BianchiSchwald advised Athyrium on the deal. The listed company Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company entered into a senior secured loan agreement with...
Basilea Pharmaceutica’s CHF 75 Million Senior Secured Loan Agreement with Athyrium
Basilea Pharmaceutica’s CHF 45.75 Million Shares Offering
Baker McKenzie advised Basilea Pharmaceutica Ltd. on all legal aspects of this PIPE transaction. Homburger advised the managers.Basilea Pharmaceutica Ltd. successfully completed a capital increase from authorized...